Internal Medicine, Gastroenterology · Worcester, MA
NPI
1326068479
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
55 Lake Ave N
Worcester, MA, 01655
Phone (508) 334-3068
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
672 services
Medicare patients, 2024
348
Average age 68
Drug cost, 2024
$708K
2,667 prescriptions
Company payments, 2025
$170
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Curtis T Barry was code 99214 (office e&m - established), 197 times for 144 patients. In total Curtis T Barry billed 672 services in 32 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 197 | 144 | $65.33 | $13K |
| 99232 Hospital E&M - Subsequent | Facility | 77 | 29 | $61.13 | $4,707 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 62 | 61 | $3.97 | $246 |
| 99222 Hospital E&M - Initial | Facility | 54 | 53 | $99.08 | $5,350 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 36 | 35 | $13.05 | $470 |
| 45385 Colonoscopy - Lesion Removal | Facility | 32 | 32 | $206.05 | $6,594 |
| 99215 Office E&M - Established | Facility | 24 | 23 | $113.97 | $2,735 |
| 99213 Office E&M - Established | Facility | 20 | 20 | $50.62 | $1,012 |
| 43235 Upper GI Endoscopy | Facility | 19 | 19 | $76.88 | $1,461 |
| 45380 Lower GI Endoscopy - Other | Facility | 18 | 18 | $54.37 | $979 |
| 43239 Upper GI Endoscopy | Facility | 18 | 18 | $90.39 | $1,627 |
| 99204 Office E&M - New | Facility | 15 | 15 | $102.99 | $1,545 |
| 91200 Standard X-ray | Facility | 14 | 14 | $8.27 | $116 |
By year: 2022 $56K for 752 services; 2023 $50K for 663 services; 2024 $47K for 672 services.
Medicare prescription drug claims, 2024
In 2024, the drug Curtis T Barry prescribed most often to Medicare patients was Tacrolimus, with 354 prescriptions and refills. In total Curtis T Barry wrote 2,667 Medicare prescriptions that cost $708K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tacrolimus Generic | 354 | 544 | 60 | $39K |
| Ursodiol Generic | 192 | 311 | 38 | $28K |
| Omeprazole Generic | 163 | 355 | 39 | $1,821 |
| Pantoprazole Sodium Generic | 128 | 201 | 30 | $918 |
| Amlodipine Besylate Generic | 114 | 249 | 29 | $418 |
| Mycophenolate Mofetil Generic | 113 | 166 | 19 | $4,034 |
| Entecavir Generic | 96 | 125 | 15 | $11K |
| Carvedilol Generic | 93 | 255 | 32 | $1,000 |
| Spironolactone Generic | 89 | 224 | 32 | $1,687 |
| Xifaxan Rifaximin | 83 | 84 | 14 | $274K |
| Prednisone Generic | 76 | 102 | 19 | $400 |
| Furosemide Generic | 73 | 159 | 26 | $411 |
| Gabapentin Generic | 53 | 73 | 12 | $639 |
| Metoprolol Tartrate Generic | 52 | 96 | Under 11 | $280 |
| Tamsulosin Hcl Generic | 44 | 56 | Under 11 | $320 |
Brand drugs: - claims; generic drugs: 2,347 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Curtis T Barry $170 ($170 in general payments such as food, travel and fees) from 1 company. The largest payer was Boston Scientific Corporation with $170.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 2 | $170 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.